Skip to main content
CDTX logo
CDTX
(NASDAQ)
Cidara Therapeutics, Inc.
$221.38-- (--)
Loading... - Market loading

Cidara Therapeutics (CDTX) Stock Price & Financial Analysis

Cidara Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$221.38 - $221.38
52-Week High$221.42
52-Week Low$15.22
Open$221.38
Market Cap5.95B
Shares Outstanding26.88M
Price to Sales (P/S)4667.62
Price to Book (P/B)14.09
EV/EBITDA-28.97
Revenue (TTM)1.27M
Net Income (TTM)-184.74M
Free Cash Flow (TTM)-133.07M
EPS (TTM)$-6.87
Profit Margin-14489.25%
Operating Margin-15330.43%
Return on Equity (ROE)-43.74%
Debt to Equity0.00
50-Day MA$190.09
200-Day MA$85.66
52-Week Change719.93%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Cidara Therapeutics

What is the current stock price for CDTX?

As of the latest trading session, CDTX stock trades at $221.38. The 52-week range is $15.22–$221.42, with a day range of $221.38–$221.38.

What is the P/E ratio for CDTX?

The P/E ratio (Price-to-Earnings) for CDTX is shown in the Key Statistics section. This valuation metric helps compare Cidara Therapeutics, Inc. to industry peers.

Does CDTX pay dividends?

Cidara Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CDTX?

Analyst ratings and recommendations for CDTX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of CDTX?

Cidara Therapeutics's market capitalization is $5.95B, classifying it as a mid-cap company. Cidara Therapeutics operates in the Healthcare sector within the Biotechnology industry.